Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction (Q47677948)

4 February 2018

title

Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction (English)

1 reference

4 February 2018

0 references

1 reference

10

1 reference

4 February 2018

Jolanda van der Velden

11

1 reference

4 February 2018

Nicky M. Boontje

5

Nicky M Boontje

1 reference

4 February 2018

Nazha Hamdani

1

Nazha Hamdani

1 reference

4 February 2018

Attila Borbély

4

Attila Borbély

1 reference

4 February 2018

Jean G F Bronzwaer

7

Jean G F Bronzwaer

1 reference

4 February 2018

Loek van Heerebeek

3

Loek van Heerebeek

1 reference

4 February 2018

author name string

Walter J Paulus

2

1 reference

4 February 2018

Marian J Zuidwijk

6

1 reference

4 February 2018

Warner S Simonides

8

1 reference

4 February 2018

Hans W M Niessen

9

1 reference

4 February 2018

publication date

31 May 2009

1 reference

4 February 2018

published in

European Heart Journal

1 reference

4 February 2018

volume

30

1 reference

4 February 2018

issue

15

1 reference

4 February 2018

page(s)

1863-1872

1 reference

4 February 2018

Trends in prevalence and outcome of heart failure with preserved ejection fraction

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP189

Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP189

Irbesartan in patients with heart failure and preserved ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP189

Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP189

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP189

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP189

Prescription of beta-blockers in patients with advanced heart failure and preserved left ventricular ejection fraction. Clinical implications and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP189

Comparison of outcomes and usefulness of carvedilol across a spectrum of left ventricular ejection fractions in patients with heart failure in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP189

Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP189

Beta-blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long-term effects of atenolol vs. nebivolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP189

How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP189

Phosphorylation and functional modifications of sarcoplasmic reticulum and myofibrils in isolated rabbit hearts stimulated with isoprenaline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP189

Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP189

CaM or cAMP: linking beta-adrenergic stimulation to 'leaky' RyRs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP189

Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP189

Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP189

Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP189

Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP189

Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP189

Stress (Takotsubo) cardiomyopathy--a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP189

Perindopril reverses myocyte remodeling in the hypertensive heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP189

Beneficial effects of bisoprolol on the survival of hypertensive diastolic heart failure model rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP189

Desmin-free cardiomyocytes and myocardial dysfunction in end stage heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP189

Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP189

Diastolic Stiffness of the Failing Diabetic Heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP189

21 January 2018

Identifiers

DOI

10.1093/EURHEARTJ/EHP189

1 reference

4 February 2018

PubMed ID

19487234

1 reference

4 February 2018